Showing results (1-10 of 40) with videos related to
Sort By:
Pageof 4
Drug Discovery Today. Technologies|July 2, 2014
Yeast as a screening toolAlcide Barberis, Tea Gunde, Catherine Berset, et al.Biotechniques|October 21, 2005
Yeast growth selection system for detecting activity and inhibition of dimerization-dependent receptor tyrosine kinaseTea Gunde, Alcide BarberisJournal of Medicinal Chemistry|August 5, 2005
Discovery of cell-permeable non-peptide inhibitors of beta-secretase by high-throughput docking and continuum electrostatics calculationsDanzhi Huang, Urs Lüthi, Peter Kolb, et al.Antimicrobial Agents and Chemotherapy|January 27, 2006
Novel yeast cell-based assay to screen for inhibitors of human cytomegalovirus protease in a high-throughput formatValérie Cottier, Alcide Barberis, Urs LüthiBiological Chemistry|July 17, 2004
Searching for the most effective screening system to identify cell-active inhibitors of beta-secretaseOliver Middendorp, Urs Lüthi, Felix Hausch, et al.Biotechniques|November 25, 2004
Quenching accumulation of toxic galactose-1-phosphate as a system to select disruption of protein-protein interactions in vivoTea Gunde, Stefan Tanner, Adrian Auf der Maur, et al.Biochimica Et Biophysica Acta|September 3, 2004
Yeast growth selection system for the identification of cell-active inhibitors of beta-secretaseOliver Middendorp, Christopher Ortler, Ulf Neumann, et al.Journal of the American Chemical Society|April 20, 2006
In silico discovery of beta-secretase inhibitorsDanzhi Huang, Urs Lüthi, Peter Kolb, et al.Biochimica Et Biophysica Acta|February 22, 2003
Human beta-secretase activity in yeast detected by a novel cellular growth selection systemUrs Lüthi, Claudia Schaerer-Brodbeck, Stefan Tanner, et al.Journal of Negative Results in Biomedicine|November 19, 2004
CP-31398, a putative p53-stabilizing molecule tested in mammalian cells and in yeast for its effects on p53 transcriptional activityStefan Tanner, Alcide BarberisPageof 4